TABLE 1.
Baseline Characteristics
| Characteristic | HIV Infected (n=32) | HIV Uninfected* (n=29) | p-value |
|---|---|---|---|
| Age, mean years (SD) | 40.0 (9.6) | 40.6 (10.8) | 0.78 |
| Gender (male) | 88% (28) | 90% (26) | 0.79 |
| Race/Ethnicity | 0.32 | ||
| White | 44% (14) | 48% (14) | |
| African American | 31% (10) | 41% (12) | |
| Other | 25% (8) | 10% (3) | |
| Smoker | 59% (19) | 41% (12) | 0.16 |
| Injection Drug Use | 38% (12) | 14% (4) | 0.04 |
| Hepatitis C | 34% (11) | 14% (4) | 0.06 |
| Diabetes Mellitus | 6% (2) | 7% (2) | 0.92 |
| Body Mass Index, mean kg/m2 (SD) | 26.0 (5.1) | 27.8 (4.5) | 0.15 |
| Systolic Blood Pressure, mean mmHg (SD) | 127.7 (13.9) | 126.7 (12.5) | 0.77 |
| Diastolic Blood Pressure, mean mmHg (SD) | 77.0 (11.3) | 74.5 (7.8) | 0.31 |
| Framingham 10yr CVD risk, mean % (SD) | 4.8 (4.6) | 3.5 (4.7) | 0.27 |
| Number with score <10% | 27 | 25 | |
| Percent (#) with score 10–20% | 5 | 4 | |
| Duration of Infection, mean years (SD) | 6.5 (6.6) | -- | |
| Prior AIDS | 7% (2) | -- | |
| Prior ART Use | 16%(5) | -- | |
| HIV RNA, mean log10 copies/mL(SD) | 4.15 (0.73) | -- | |
| CD4 Count (cells/mm3) | |||
| Mean (SD) | 391 (182) | -- | |
| Median (IQR) | 382 (255–514) | -- | |
Data presented are percent (no.) unless otherwise specified
*
Attempt was made to match HIV uninfected group on age, gender, race/ethnicity, smoking status and diabetes